Spasticity is one of the main symptoms that is most common in patients with Multiple Sclerosis and causes increased disability. The aim of this study is to understand the experiences of patients with Multiple Sclerosis about their spasticity from their perspective. This study was conducted as a qualitative study with a Hermeneutic phenomenological framework. The data were evaluated by using VanManen’s thematic analysis method. As a result of the data analysis, four main themes were elicited, namely, “the meaning of spasticity for the patient,” “the difficulties of living with spasticity,” ‘coping with spasticity,” and “the new me created by spasticity.” It was understood that spasticity is a symptom that brings about difficulties in psychological, social, and working life as well as physical difficulties. Nurses should be aware of the psychological symptoms as well as the physical symptoms that patients experience due to spasticity and should create a patient-specific management program.
AkpinarP.AticiA.OzkanF. U.AktasI.KulcuD. G.SarıA.DurmusB. (2017). Reliability of the modified Ashworth scale and modified Tardieu scale in patients with spinal cord injuries. Spinal Cord, 55(10), 944–949. https://doi.org/10.1038/sc.2017.48
2.
AlorainiS. M.AlyosufE. Y.AlorainiL. I.AldaihanM. M. (2022). Assessment of spasticity: An overview of systematic reviews. Physical Therapy Reviews, 1–14. https://doi.org/10.1080/10833196.2022.2059942
3.
AmatyaB.KhanF.La MantiaL.DemetriosM.WadeD. T. (2013). Nonpharmacological interventions for spasticity in multiple sclerosis. Cochrane Database of Systematic Reviews, 2, CD009974. https://doi.org/10.1002/14651858.CD009974.pub2
4.
ArroyoR.MassanaM.VilaC. (2013). Correlation between spasticity and quality of life in patients with multiple sclerosis: The CANDLE study. International Journal of Neuroscience, 123(12), 850–858. https://doi.org/10.3109/00207454.2013.812084
5.
AshworthB. (1964). Preliminary trial of carisoprodal in multiple sclerosis. Practitioner, 192, 540–542.
6.
BarnesM.KocerS.Murie FernandezM.BalcaitieneJ.FheodoroffK. (2017). An international survey of patients living with spasticity. Disability and Rehabilitation, 39(14), 1428–1434. https://doi.org/10.1080/09638288.2016.1198432
7.
BenderM. S.JansonS. L.FranckL. S.LeeK. A. (2018). Theory of symptom management. In JaneS. M.PatriciaL. (Eds.), Middle range theory for nursing, (pp. 147–178). Springer.
8.
BethouxF.MarrieR. A. (2016). A cross-sectional study of the impact of spasticity on daily activities in multiple sclerosis. The Patient-Patient-Centered Outcomes Research, 9(6), 537–546. https://doi.org/10.1007/s40271-016-0173-0
9.
BhimaniR.AndersonL. (2014). Clinical understanding of spasticity: Implications for practice. Rehabilitation Research and Practice, 2014, 279175. https://doi.org/10.1155/2014/279175
10.
BhimaniR. H.McAlpineC. P.HenlyS. J. (2012). Understanding spasticity from patients’ perspectives over time. Journal of Advanced Nursing, 68(11), 2504–2514. https://doi.org/10.1111/j.1365-2648.2012.05949.x
11.
ComiG.SolariA.LeocaniL.CentonzeD.Otero-RomeroS.AmadeoR.AmatoM. P.BertolottoA.BoffaL. (2020). Italian consensus on the treatment of spasticity in multiple sclerosis. European Journal of Neurology, 27(3), 445–453. https://doi.org/10.1111/ene.14110
12.
Cwiekala-LewisK.ParkynBHModliszewskaK (2017). Analysis of University of California in San Francisco (UCSF) symptom management theory and theory implication for persons with neurological disorders/diseases. Journal of Neurological and Neurosurgical Nursing, 6(2), 55–65.
13.
FarrarJ. T.TroxelA. B.StottC.DuncombeP.JensenM. P. (2008). Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: A post hoc analysis of a randomized, double-blind, placebo-controlled trial. Clinical Therapeutics, 30(5), 974–985. https://doi.org/10.1016/j.clinthera.2008.05.011
14.
FlacheneckerP.HenzeT.ZettlU. K. (2014). Spasticity in patients with multiple sclerosis–clinical characteristics, treatment, and quality of life. Acta Neurologica Scandinavica, 129(3), 154–162. https://doi.org/10.1111/ane.12202
15.
GreggJ. A. (2013). Self-acceptance and chronic illness. In BernardM. (Ed.), The strength of self-acceptance (pp. 247–262). Springer. https://doi.org/10.1007/978-1-4614-6806-6_14
16.
GustavsenS.OlssonA.SøndergaardH. B.AndresenS. R.SørensenP. S.SellebjergF.OturaiA. (2021). The association of selected multiple sclerosis symptoms with disability and quality of life: A large Danish self-report survey. BMC Neurology, 21(1), 1–12. https://doi.org/10.1186/s12883-021-02344-z
17.
HeideggerM. (2010). Phenomenology of intuition and expression. Bloomsbury Publishing.
18.
Horrigan-KellyM.MillarM.DowlingM. (2016). Understanding the key tenets of Heidegger’s philosophy for interpretive phenomenological research. International Journal of Qualitative Methods, 15(1), 1609406916680634.
19.
HugosC. L.CameronM. H. (2019). Assessment and measurement of spasticity in MS: State of the evidence. Current Neurology and Neuroscience Reports, 19(10), 79. https://doi.org/10.1007/s11910-019-0991-2
20.
LakinL.DavisB. E.BinnsC. C.CurrieK. M.RenselM. R. (2021). A comprehensive approach to the management of multiple sclerosis: Addressing invisible symptoms—a narrative review. Neurology and Therapy, 10, 75–98. https://doi.org/10.1007/s40120-021-00239-2
21.
MaguireR.HanlyP.MaguireP. (2021). Living well with chronic illness: How social support, lonelines, and psychological appraisals relate to well-being in a population-based European sample. Journal of Health Psychology, 26(10), 1494–1507. https://doi.org/10.1177/1359105319883923
22.
MorleyA.TodA.CrampM.MawsonS. (2013). The meaning of spasticity to people with multiple sclerosis: What can health professionals learn?Disability and Rehabilitation, 35(15), 1284–1292. https://doi.org/10.3109/09638288.2012.726691
23.
NaroA.LeoA.RussoM.CasellaC.BudaA.CrespantiniA.PorcariB.CariotiL.BilleriL.BramantiA. (2017). Breakthroughs in the spasticity management: Are non-pharmacological treatments the future?Journal of Clinical Neuroscience, 39, 16–27. https://doi.org/10.1016/j.jocn.2017.02.044
24.
NicolsonP.AndersonP. (2001). The psychosocial impact of spasticity-related problems for people with multiple sclerosis: A focus group study. Journal of Health Psychology, 6(5), 551–567. https://doi.org/10.1177/135910530100600508
25.
Oreja-GuevaraC.González-SeguraD.VilaC. (2013). Spasticity in multiple sclerosis: Results of a patient survey. International Journal of Neuroscience, 123(6), 400–408. https://doi.org/10.3109/00207454.2012.762364
26.
PatejdlR.ZettlU. K. (2017). Spasticity in multiple sclerosis: Contribution of inflammation, autoimmune-mediated neuronal damage, and therapeutic interventions. Autoimmunity Reviews, 16(9), 925–936. https://doi.org/10.1016/j.autrev.2017.07.004
27.
PattiF.VilaC. (2014). Symptoms, prevalence, and impact of multiple sclerosis in younger patients: A multinational survey. Neuroepidemiology, 42(4), 211–218. https://doi.org/10.1159/000360423
28.
PozzilliC. (2013). Advances in the management of multiple sclerosis spasticity: Experiences from recent studies and everyday clinical practice. Expert Review of Neurotherapeutics, 13(sup2), 49–54. https://doi.org/10.1586/14737175.2013.865877
29.
RomanC.MenningK. (2017). Treatment and disease management of multiple sclerosis patients: A review for nurse practitioners. Journal of the American Association of Nurse Practitioners, 29(10), 629–638. https://doi.org/10.1002/2327-6924.12514
30.
Van ManenM. (2016). Phenomenology of practice: Meaning-giving methods in phenomenological research and writing (1st ed.). Routledge. https://doi.org/10.4324/9781315422657
